Nephrology Times

The Kidney Transplant Landscape | Docwire News Richard Knight, MD, discusses challenges in human and pig kidney transplantation and how machine learning and other advances can help.

👓 WATCH NOW: Richard Knight, MD, talks about ongoing challenges in kidney transplantation and how emerging tools and strategic policies might help. #kidneytransplant #transplantation #nephrology #nephsky www.docwirenews.com/post/the-kid...

Hyperkalemia With Empagliflozin and Finerenone | Docwire News Joel Topf, MD, interviewed Rajiv Agarwal, MBBS, about an implementation analysis of CONFIDENCE findings on hyperkalemia with finerenone and empagliflozin in chronic kidney disease.

👀 WATCH NOW: Joel Topf @kidneyboy.bsky.social caught up with Rajiv Agarwal at #KidneyWk in Houston, where the latter presented CONFIDENCE findings on implementation of finerenone and empagliflozin. #nephrology #nephsky #kidneydisease #hyperkalemia #sglt2 www.docwirenews.com/post/hyperka...

Mezagitamab, Atacicept, and the Rise of IgAN Therapies | Docwire News Joel Topf, MD, spoke with Jonathan Barratt, PhD, about his Kidney Week presentations on mezagitamab and atacicept and the landscape of IgA nephropathy (IgAN).

Another #KidneyWk, another showcase for #IgAN therapies. Joel Topf @kidneyboy.bsky.social spoke with Jonathan Barratt about his trials of mezagitamab and atacicept. #nephsky #nephrology #iganephropathy www.docwirenews.com/post/mezagit...

5 Highlights from ASN Kidney Week 2025 | Docwire News ASN Kidney Week included the FINE-ONE type 1 diabetes trial, PISCES trial of fish oil in dialysis, a new research grant, and lectures on public health and renal drug development.

Check out 5 of our favorite highlights from ASN #KidneyWk. #nephrology #nephsky www.docwirenews.com/post/5-highl...

Sparsentan and the 0.7 g/g Proteinuria Threshold in FSGS | Docwire News Drs. Joel Topf and Jai Radhakrishnan discuss an analysis of data from the DUPLEX trial of sparsentan in focal segmental glomerulosclerosis (FSGS) and trial end points for FSGS.

Joel Topf @kidneyboy.bsky.social spoke with Jai Radhakrishnan at #KidneyWk about his late-breaking research poster describing a new analysis of data from the DUPLEX trial of sparsentan in #FSGS. #nephsky #nephrology www.docwirenews.com/post/sparsen...

Trials Update: Finerenone in T1D, Balcinrenone, and More | Docwire News Joel Topf and Hiddo Heerspink discuss finerenone in type 1 diabetes and kidney disease (FINE-ONE), the MRA balcinrenone, and renal trial end points.

At #KidneyWk, we spoke with Hiddo J. L. Heerspink about the FINE-ONE trial and the first meaningful progress in T1D kidney disease in decades. #nephrology #nephsky #diabetes #kidneydisease www.docwirenews.com/post/trials-...

Curing Kidney Disease: What’s Changing in DKD and IgAN | Docwire News At ASN Kidney Week 2025, Drs. Joel Topf and Vlado Perkovic discussed curing kidney disease and high-impact trials in diabetic kidney disease and IgA nephropathy (IgAN).

Our #KidneyWk coverage continues to roll out. Next up is our interview with Vlado Perkovic on the possibility of curing #kidneydisease and his take on the FINE-ONE and ORIGIN-3 trials presented on day 1 of the meeting. #nephrology #nephsky www.docwirenews.com/post/curing-...

KidneyCure Commits $6 Million to Support Researchers Affected by NIH Funding Cuts | Docwire News KidneyCure, the philanthropic foundation of the American Society of Nephrology (ASN), will invest $6 million in research grants to support kidney researchers affected by NIH cuts.

ICYMI: KidneyCure, the philanthropic arm of ASN, will invest up to $6M in grants over 3 years to support kidney research. #kidneydisease #research #nephrology
www.docwirenews.com/post/kidneyc...

ASN Kidney Week 2025 Day 2 Highlights | Docwire News Nephrology Times board members Joel Topf, MD, and Anna Gaddy, MD, met at American Society of Nephrology (ASN) Kidney Week 2025 in Houston to discuss day 2's highlights.

Don't miss part 2 of #KidneyWk highlights from @kidneyboy.bsky.social and @annagaddy.bsky.social. #nephsky #nephrology www.docwirenews.com/post/asn-kid...

🚨Attention #KidneyCare professionals!🚨 Registration is OPEN for @kidney.org 2026 Spring Clinical Meetings! Take advantage of early bird discounted rates and explore the latest in clinical research, patient care, and professional development in #nephrology.
Learn More: www.kidney.org/spring-clini...

Thank you @brianrifkin.bsky.social @katiekwonmd.bsky.social @captainchloride.bsky.social for your input!

5 Nephrologists, 1 Question: Discussing Prognosis in Advanced Kidney Disease | Docwire News In this recurring section, Nephrology Times asked five nephrologists: How do you discuss prognosis in advanced kidney disease?

How would you discuss prognosis in advanced kidney disease with a patient? Five nephrologists share their opinions. #nephrology #nephsky #kidneydisease www.docwirenews.com/post/5-nephr...

ASN Kidney Week 2025 Day 1 Highlights | Docwire News Nephrology Times board members Joel Topf, MD, and Anna Gaddy, MD, met at American Society of Nephrology (ASN) Kidney Week 2025 in Houston to discuss day 1's highlights.

Miss out on #KidneyWk? Catch up with day 1's highlights courtesy of Drs. Joel Topf and Anna Gaddy. @kidneyboy.bsky.social #nephrology #nephsky #kidneydisease
www.docwirenews.com/post/asn-kid...

Hey #NephSky: Would you like to contribute your answer to our next "5 Nephrologists, 1 Question" column? The question: What recent research has most changed your approach to managing glomerulonephritis? If you want to answer this or a future question, drop a comment.

PISCES Fish Oil Data Make a Splash | Docwire News PISCES trial data presented at Kidney Week 2025 showed that daily fish oil supplements lowered the rate of serious cardiovascular events for patients on maintenance hemodialysis.

One of the surprises of ASN Kidney Week was the PISCES trial presentation, showing that there may be a simple way to greatly improve CV outcomes in hemodialysis. #kidneywk #nephsky #nephrology #hemodialysis www.docwirenews.com/post/pisces-...

When the Payer Is the Problem: Building Better Escalation Pathways | Docwire News In her column, Sarah Tolson examines when and how to escalate a payer dispute beyond the payer itself.

Sarah Tolson shares an example of how to challenge claim denials when all avenues involving the payer have been exhausted. #medicalbilling #claims #nephrology #reimbursement www.docwirenews.com/post/when-th...

When Public Policy Makes a Meaningful Difference to Patient Lives | Docwire News OPTN policies to correct racial inequities, including adopting the race-free equation for estimating glomerular filtration rate, are giving Black kidney transplant candidates hope.

Editorial chair Dr. Ajay Singh discusses how removing race from eGFR equations turned conviction into conduct and gave Black transplant candidates fairer access to kidney transplantation. #nephrology #kidneytransplantation #healthequity www.docwirenews.com/post/when-pu...

ASN Kidney Week 2025 | Docwire News Review highlights from abstracts and presentations at ASN Kidney Week 2025, presented by the American Society of Nephrology, on Nephrology Times

WHEW! ASN #KidneyWk wraps up today, kicking off with a talk on xenotransplantation and wrapping up with a special session on the IOTA Model. DON'T FORGET to check our website for more coverage. www.docwirenews.com/conference/a... #nephrology #kidneytransplantation

ASN Kidney Week 2025 | Docwire News Review highlights from abstracts and presentations at ASN Kidney Week 2025, presented by the American Society of Nephrology, on Nephrology Times

✈️ We're heading home from ASN #KidneyWk but can't wait to share more from the event with you. Keep an eye on our website for Dr. Joel Topf's interviews with presenters. @asnkidney.bsky.social @kidneyboy.bsky.social #nephrology www.docwirenews.com/conference/a...

Another ovation, for Reshma Kewalramani’s talk. #KidneyWk

Michelle Josephson, winner of Barbara Murphy Award. #KidneyWk

Michael Allon accepting the Belding Scribner Award. #KidneyWk

It’s the last day of #KidneyWk — don’t head home without visiting the ASN Membership Booth! Stop by between 7:30 a.m.–2:30 p.m. CST to renew or join for 2026 and stay connected to ASN resources, opportunities, and the kidney community year-round.

Next up is Biff Palmer receiving the Robert Narins Award. #KidneyWk

“I hope I didn’t bring you down,” he said. Judging from the ovation, probably the opposite.

Califf pointing out huge disparities in U.S. Worst longevity of high income nations, but people with lots of money can live a long life.

Day 3 at #KidneyWk as Robert Califf receives the President’s Medal.

Another stellar day at #KidneyWk. Today Joel Topf @kidneyboy.bsky.social spoke with Jonathan Barratt, Hiddo Heerspink, Vesna Garovic, and others. Keep an eye on nephtimes.com for all our coverage.

We are 2 for 2 with positive trials so far. LIBERATE-D shows benefit with a conservative vs conventional dialysis strategy in AKI-D. The difference in mortality is concerning though? Simultaneous pub 👇🏾 #kidneywk

jamanetwork.com/journals/jam...

Reshma Kewalramani MD FASN will deliver a state-of-the-art lecture titled “On Kidney Medicine, Drug Development, and Coming Home” at a plenary session on Saturday, November 8 at #KidneyWk. Read more about her and her work in #ASNKidneyNews: kidney.pub/KN1710-49